AttendMe Owl Logo
AttendMe
Evidence Evolution
Emergency MedicineEmergency Medicine

How This Evidence Evolved

Chest Pain Risk Stratification

Safe early discharge from the emergency department

6.1

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Chest-pain assessment must distinguish patients at low and high risk of acute coronary syndrome. A prospective study validated the HEART Score in 2440 unselected chest-pain patients at ten Dutch cardiac emergency departments and compared it with TIMI and GRACE. The endpoint was major adverse cardiac events within six weeks. MACE occurred in 1.7% of patients with HEART scores 0–3, 16.6% with scores 4–6, and 50.1% with scores 7–10.
Proof

Landmark RCTs and pivotal trials that established the evidence base

The HEART Pathway RCT used the HEART score plus troponin measures at 0 and 3 hours to identify ED patients for early discharge. Compared with usual care, it cut objective cardiac testing at 30 days by 12.1 percentage points (56.7% vs 68.8%) and raised early discharge by 21.3 percentage points (39.7% vs 18.4%), with no 30-day MACE among early discharges. The TRAPID-AMI study (2016) validated a 0/1-hour hs-troponin T algorithm: 96.7% sensitivity and 99.1% NPV for rule-out. The High-STEACS trial (2018) across 48,282 patients found that introducing a hs-troponin I assay did not lower 1-year MI or cardiovascular death in reclassified patients (adjusted OR 1.10, 95% CI 0.75-1.61).
Guidelines

Integration into clinical practice guidelines and recommendations

The HEART Pathway trial separately tested the HEART score with troponin at zero and three hours; it did not test a combined HEART and high-sensitivity zero/one-hour pathway.
Now

Current standard of care and ongoing research directions

The HEART Pathway trial used the score with zero/three-hour troponins, shortened stay and increased early discharge; no early-discharge patients had 30-day MACE. HiSTORIC tested an initial hs-cTnI <5 ng/L pathway. The RAPIDx AI protocol describes a cluster-randomized trial of machine-learning decision support.

Landmark Trials in This Story

HEART Score2013Landmark

A prospective validation of the HEART score for chest pain patients at the emergency department

HEART score 0-3: 6-week MACE rate 1.7%, identifying 36.4% of patients as low-risk

International journal of cardiologyProspective validationN=2,440
HEART Pathway2015Landmark

The HEART Pathway randomized trial: identifying emergency department patients with acute chest pain for early discharge

Objective cardiac testing at 30 days: HEART Pathway 56.7% vs usual care 68.8% (P=0.048); no MACE in early discharges

Circulation. Cardiovascular quality and outcomesRCTN=282
TRAPID-AMI2016Landmark

Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T

0/1h rule-out: sensitivity 96.7% (95% CI 93.4-98.7), NPV 99.1% (98.2-99.7)

Annals of emergency medicineProspective diagnostic studyN=1,282
High-STEACS2018Landmark

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial

Reclassified: no reduction in 1-year MI/CV death: implementation 12% vs validation 15% (adjusted OR 1.10, 95% CI 0.75–1.61)

LancetStepped-wedge cluster RCTN=48,282
HiSTORIC2021

High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial

Length of stay 10.1 → 6.8 h; discharge 50% → 71%; 30-day MI or cardiac death 0.3% after vs 0.4% before implementation (non-inferiority not demonstrated, margin 0.5%, p=0.068); 1-year events 1.8% vs 2.7%

CirculationStepped-wedge cluster RCTN=31,492
RAPIDx AI2025

Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting research evidence to practice using artificial intelligence. (RAPIDx AI)-a cluster randomized study design.

Planned 12-month composite: cardiovascular mortality, new or recurrent MI, and unplanned hospital readmission

American heart journalCluster-randomized clinical trial protocol

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

What is the HEART score for chest pain?+
In the separate HEART Pathway trial, the score plus zero/three-hour troponins identified early-discharge patients; none had MACE within 30 days. The score alone was not that trial’s discharge strategy.
How has chest pain management changed in emergency departments?+
In the HEART Pathway randomized trial, the score plus zero/three-hour troponins reduced stay from 21.9 to 9.9 hours and increased early discharge from 18.4% to 39.7%. No patients identified for early discharge had MACE within 30 days. This trial did not test combined HEART and high-sensitivity zero/one-hour algorithms.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026